BR9407415A - Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine - Google Patents
Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeineInfo
- Publication number
- BR9407415A BR9407415A BR9407415A BR9407415A BR9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A
- Authority
- BR
- Brazil
- Prior art keywords
- caffeine
- compositions containing
- steroidal anti
- inflammatory agent
- amino acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11738993A | 1993-09-07 | 1993-09-07 | |
PCT/US1994/009582 WO1995007079A1 (en) | 1993-09-07 | 1994-08-24 | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9407415A true BR9407415A (en) | 1996-11-12 |
Family
ID=22372657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9407415A BR9407415A (en) | 1993-09-07 | 1994-08-24 | Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0717624A1 (en) |
JP (1) | JPH09502202A (en) |
AU (1) | AU7604194A (en) |
BR (1) | BR9407415A (en) |
CA (1) | CA2170485C (en) |
WO (1) | WO1995007079A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
ATE299699T1 (en) * | 1996-05-20 | 2005-08-15 | Searle Llc | MEDICINAL PRODUCTS CONTAINING OXAPROZIN SODIUM SALT, POTASSIUM SALT, OR TRIS(HYDROXYMETHYL)AMINOMETHANE SALT |
CN1263464A (en) | 1998-04-11 | 2000-08-16 | 伊利卡帕·尤罗特拉皮西有限公司 | Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application |
BR9911917A (en) | 1998-07-09 | 2001-03-27 | Warner Lambert Co | Compositions comprising gaba and caffeine analogs |
US6211246B1 (en) * | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
US7166641B2 (en) * | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
TWI313598B (en) | 2002-12-18 | 2009-08-21 | Wyeth Corp | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
US9149474B2 (en) | 2011-11-23 | 2015-10-06 | Michael Leighton | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
US9629847B2 (en) | 2011-11-23 | 2017-04-25 | Michael Leighton | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
EP3406239B1 (en) * | 2017-05-22 | 2021-10-20 | Epifarma Srl | Palatable ketoprofen lysine salt solutions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4420483A (en) * | 1982-07-22 | 1983-12-13 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same |
DE3328401A1 (en) * | 1983-08-05 | 1985-02-21 | Merckle GmbH, 7902 Blaubeuren | INJECTABLE SOLUTION FOR TREATING INFLAMMATION |
WO1991006295A1 (en) * | 1989-11-06 | 1991-05-16 | Sepracor, Inc. | Analgesic composition containing optically pure s(+) flurbiprofen |
US4994604A (en) * | 1990-01-10 | 1991-02-19 | Merck & Co., Inc. | Formation and resolution of ibuprofen lysinate |
CA2144152A1 (en) * | 1992-09-29 | 1994-04-14 | Robert T. Sims | Ibuprofen-caffine combinations |
WO1994014449A1 (en) * | 1992-12-21 | 1994-07-07 | The Procter & Gamble Company | Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen |
WO1994016703A1 (en) * | 1993-01-29 | 1994-08-04 | Merck & Co., Inc. | Ciclobenzaprine-caffeine combination as a muscle relaxant |
-
1994
- 1994-08-24 EP EP94926021A patent/EP0717624A1/en not_active Withdrawn
- 1994-08-24 AU AU76041/94A patent/AU7604194A/en not_active Abandoned
- 1994-08-24 WO PCT/US1994/009582 patent/WO1995007079A1/en not_active Application Discontinuation
- 1994-08-24 JP JP7508696A patent/JPH09502202A/en active Pending
- 1994-08-24 BR BR9407415A patent/BR9407415A/en not_active Application Discontinuation
- 1994-08-24 CA CA002170485A patent/CA2170485C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2170485C (en) | 2000-11-07 |
EP0717624A1 (en) | 1996-06-26 |
JPH09502202A (en) | 1997-03-04 |
AU7604194A (en) | 1995-03-27 |
CA2170485A1 (en) | 1995-03-16 |
WO1995007079A1 (en) | 1995-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9407414A (en) | Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive | |
BR9407415A (en) | Compositions containing a non-steroidal anti-inflammatory agent amino acid salt of propionic acid and caffeine | |
HUT75089A (en) | Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent | |
ITMI931324A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF S(+)-2-(4-ISOBUTYLPHENYL) PROPIONIC ACID WITH BASIC AMINO ACIDS | |
IL113433A0 (en) | Tablet formulations comprising amoxycillin and salts of clavulanic acid | |
AU3590489A (en) | Use of gamma-hydroxybutyric acid salts in the treatment of alcoholism and pharmaceutical compositions thereof | |
NO924978L (en) | CHINOLON AND NAFTYRIDON CARBOXYLIC ACID DERIVATIVES | |
SG50636A1 (en) | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof | |
GB9710644D0 (en) | Asiatic acid derivatives it's manufacturing method and dermatological agent containing it | |
SG67283A1 (en) | Sulphonic acid esters radiation-sensitive mixtures made therewith and their use | |
HU9502520D0 (en) | Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives | |
KR920701213A (en) | Methylenediphosphonic acid compound and anti-inflammatory agent using it as an active ingredient | |
DE69512929D1 (en) | SALTS OF AMINO ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
BR9610388A (en) | Pyrimidine compound or an acid addition salt thereof for the preparation of a pyrimidine and pharmaceutical formulation | |
AU2988992A (en) | Ammonium salt of pyrimidyl-substituted benzoic acid and its use as a herbicide | |
NO180794C (en) | Novel amidoalkyl and imidoalkylpiperazines and pharmaceutical preparations containing such compounds | |
AU7001796A (en) | Benzoic acid compounds and medicinal use thereof | |
IL108920A0 (en) | Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them | |
NO951933L (en) | Pharmaceutical formulations of ibuprofen | |
BR9307697A (en) | Compositions containing caffeine and s (+) - ibuprofen or s (+) - flubiprofen or s (+) - quetoprofen | |
HUP0001866A3 (en) | Salts of l-carnitine and alkanoyl-l-carnitine derivatives with 2-aminoethanesulfonic acid and pharmaceutical compositions containing them | |
GB9304745D0 (en) | Use of pharmaceutical formulations | |
DE69420346D1 (en) | DERMATOLOGICAL PREPARATIONS AND NEW BENZOIC ACID DERIVATIVES | |
HU9601420D0 (en) | Derivatives of 2,3,5,6-tetrafluorobenzoic acid and their use in combating pests | |
AU7499094A (en) | Poorly water-soluble salts of sunscreen agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
CKFC | Appeal: appeal against refusal |